R. C. Patel College of Pharmacy (RCPIPER) was established in 1992 with the primary objective of providing value based health and technical education to aspiring candidates and mould out of them citizens who will make India proud in the 21st Century. The institute also aims for all-round development of the students to help them realize their full potential and career goals.
CSIR-Central Drug Research Institute, Lucknow is a premier R&D Institute under the aegis of the Council of Scientific and Industrial Research (CSIR), New Delhi which is an autonomous body under Department of Scientific and Industrial Research, Government of India.
Nirma University (NU) was established in the year 2003 as a Statutory University under a Special Act passed by the Gujarat State Legislative Assembly. The University Grants Commission (UGC) has recognized Nirma University under Section 2(f) and the University is also accredited by National Assessment and Accreditation Council (NAAC). Nirma University is a member of the Association of Indian Universities (AIU) and the Association of Commonwealth Universities (ACU).
CSIR- OSDD with Vigyan Prasar is conducting a YouTube based short video competition on "The Need of New Drugs for Tuberculosis". All individuals, including students above 18 years of age, educational institutions and organizations are invited to participate in the contest, and win attractive prizes !!!
Biocon Limited, Asia's premier biotechnology company, announced that it has received global recognition from the ‘Science’ Magazine which features Biocon in its annual Global ‘Top Twenty Employer’ list for the Bio pharma sector. According to the 2012 Top Biotech and Pharma Employers survey, Biocon has been ranked at No 19. Biocon is the only Asian Company to be a part of the Top 20 Elite List which includes leading global innovator companies.
LifeCell International, India’s largest and most accredited stem cell storage company launches "BabyShield", the world’s most advanced and non-invasive newborn screening program.
Combined hormonal contraceptives (CHCs) put women at increased risk of venous thromboembolic events (VTEs) and arterial thrombotic events (ATEs), including acute myocardial infarction and ischemic stroke, according to results from a retrospective study that included more than a half million new users of contraceptives. The study was published online October 22 in Contraception.
MILLENNIUM COLLEGE OF PHARMACY, In line with our vision of providing an exciting and challenging learning and research environment designed to develop independent, innovative and creative ideas, the institution has Bachelors and Master degree courses..
Copyright © 2008-2019, PharmaTutor Edu Labs
Recent Topics